Your browser doesn't support javascript.
loading
Efficient production of Tymovirus like particles displaying immunodominant epitopes of Japanese Encephalitis Virus envelope protein.
Shahana, Pallichera Vijayan; Das, Dipankar; Gontu, Abhinay; Chandran, Dev; Maithal, Kapil.
Afiliação
  • Shahana PV; Indian Immunologicals Limited, Rakshapuram, Gachibowli, Hyderabad 500032, Telangana, India; Department of Biotechnology, Acharya Nagarjuna University, Nagarjunanagar, Guntur 522510, Andhra Pradesh, India.
  • Das D; Indian Immunologicals Limited, Rakshapuram, Gachibowli, Hyderabad 500032, Telangana, India.
  • Gontu A; Indian Immunologicals Limited, Rakshapuram, Gachibowli, Hyderabad 500032, Telangana, India.
  • Chandran D; Indian Immunologicals Limited, Rakshapuram, Gachibowli, Hyderabad 500032, Telangana, India.
  • Maithal K; Indian Immunologicals Limited, Rakshapuram, Gachibowli, Hyderabad 500032, Telangana, India. Electronic address: kapil.maithal@indimmune.com.
Protein Expr Purif ; 113: 35-43, 2015 Sep.
Article em En | MEDLINE | ID: mdl-25959459
Japanese Encephalitis (JE) is a mosquito borne arboviral infection caused by Japanese Encephalitis Virus (JEV). It is a major cause of viral encephalitis in Asian countries including India. In the present study, we have used a Tymovirus [i.e. Physalis Mottle Virus (PhMV) coat protein (CP)], which forms virus like particles (VLPs) as a template to display immunodominant epitopes of JEV envelope (E) protein. The immunodominant epitopes of JEV were inserted at the N-terminus of the wild type PhMV CP, and these constructs were cloned and expressed in Escherichia coli. The chimeric proteins were purified from the inclusion bodies and evaluated for VLP formation. The purified protein was identified by Western blotting and VLP formation was studied and confirmed by transmission electron microscopy and dynamic light scattering. Finally, the immunogenicity was studied in mice. Our results indicate that the chimeric protein with JEV epitopes assembled efficiently to form VLPs generating neutralizing antibodies. Hence, we report the purified chimeric VLP would be a potent vaccine candidate, which needs to be evaluated in a mouse challenge model.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Glicoproteínas de Membrana / Proteínas do Envelope Viral / Epitopos Imunodominantes / Tymovirus / Proteínas do Capsídeo / Corpos de Inclusão Viral Limite: Animals Idioma: En Revista: Protein Expr Purif Assunto da revista: BIOLOGIA MOLECULAR Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Índia

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Glicoproteínas de Membrana / Proteínas do Envelope Viral / Epitopos Imunodominantes / Tymovirus / Proteínas do Capsídeo / Corpos de Inclusão Viral Limite: Animals Idioma: En Revista: Protein Expr Purif Assunto da revista: BIOLOGIA MOLECULAR Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Índia